© Copyright 2001-2023 Erowid Center. DrugsData is a project of
Erowid Center. All rights reserved.
By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center.
Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems.
This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.
Your javascript is turned off.
To remove this message, turn on javascript and accept the Terms of Use.
Two submission forms were submitted with these samples, one for material sold as MDMA and described as ''white powder/crystals blue tint'', and the other one for material sold as 2C-B and described as ''white powder''.
The submission form for the material sold as MDMA and described as ''white powder/crystals blue tint'' accompanied the soft white powder. The material sold as 2C-B and described as ''white powder'' accompanied the purplish/brownish crystalline powder.
Because of the actual content of these two powders -- GC/MS showed the soft white powder to be 2C-B, and the purplish crystalline powder to be MDMA -- it is the DrugsData crew's belief that each submission form arrived at the lab accompanying the wrong powder, that they effectively arrived switched.
We've confirmed the sample of soft white powder pictured above is 2C-B. If you sent in these two samples, the descriptions of the physical characteristics of the powders might reassure you that the submission forms were switched. Or, you can reagent-test them to distinguish the MDMA from the 2C-B to be double sure.
*tl;dr This white powder, confirmed to be 2C-B arrived at the lab with a submission form for a sample sold as MDMA.*
Contact info (at) drugsdata (dot) org about samples #15399 and #15400 if you have any questions.